BioHarvest Sciences Inc. Common Stock
BHST · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $25,188 | $12,672 | $5,498 | $2,102 |
| % Growth | 98.8% | 130.5% | 161.6% | – |
| Cost of Goods Sold | $11,246 | $7,039 | $4,279 | $1,432 |
| Gross Profit | $13,942 | $5,633 | $1,219 | $670 |
| % Margin | 55.4% | 44.5% | 22.2% | 31.9% |
| R&D Expenses | $4,797 | $3,369 | $2,308 | $4,129 |
| G&A Expenses | $6,473 | $5,680 | $5,050 | $1,801 |
| SG&A Expenses | $15,735 | $12,076 | $9,352 | $4,759 |
| Sales & Mktg Exp. | $9,262 | $6,396 | $4,302 | $2,958 |
| Other Operating Expenses | $399 | $154 | $171 | $273 |
| Operating Expenses | $20,931 | $15,599 | $11,831 | $9,161 |
| Operating Income | -$6,989 | -$9,966 | -$10,612 | -$8,491 |
| % Margin | -27.7% | -78.6% | -193% | -403.9% |
| Other Income/Exp. Net | -$5,916 | -$2,598 | -$624 | -$1,336 |
| Pre-Tax Income | -$12,905 | -$12,564 | -$11,236 | -$9,827 |
| Tax Expense | $8 | $0 | $0 | $0 |
| Net Income | -$12,913 | -$12,564 | -$11,236 | -$9,827 |
| % Margin | -51.3% | -99.1% | -204.4% | -467.5% |
| EPS | -0.8 | -0.93 | -0.7 | -0.7 |
| % Growth | 14% | -32.9% | 0% | – |
| EPS Diluted | -0.8 | -0.93 | -0.7 | -0.7 |
| Weighted Avg Shares Out | 16,194 | 13,533 | 13,054 | 12,448 |
| Weighted Avg Shares Out Dil | 16,194 | 13,533 | 13,054 | 12,448 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,930 | $1,962 | $1,399 | $805 |
| Depreciation & Amortization | $1,251 | $840 | $712 | $386 |
| EBITDA | -$9,724 | -$9,762 | -$9,125 | -$8,636 |
| % Margin | -38.6% | -77% | -166% | -410.9% |